Literature DB >> 24080357

Mutation in CYP27A1 identified in family with coronary artery disease.

Kolsoum Inanloorahatloo1, Amir Farhang Zand Parsa, Klaus Huse, Paniz Rasooli, Saeid Davaran, Matthias Platzer, Jian-Bing Fan, Sasan Amini, Frank Steemers, Elahe Elahi.   

Abstract

Coronary artery disease (CAD) is a leading cause of death worldwide. Myocardial infarction is the most severe outcome of CAD. Despite extensive efforts, the genetics of CAD is poorly understood. We aimed to identify the genetic cause of CAD in a pedigree with several affected individuals. Exome sequencing led to identification of a mutation in CYP27A1 that causes p.Arg225His in the encoded protein sterol 27-hydroxylase as the likely cause of CAD in the pedigree. The enzyme is multifunctional, and several of its functions including its functions in vitamin D metabolism and reverse cholesterol transport (RCT) are relevant to the CAD phenotype. Measurements of vitamin D levels suggested that the mutation does not affect CAD by affecting this parameter. We suggest that the mutation may cause CAD by affecting RCT. Screening of all coding regions of the CYP27A1 in 100 additional patients led to finding four variations (p.Arg14Gly, p.Arg26Lys, p.Ala27Arg, and p.Val86Met) in seven patients that may contribute to their CAD status. CYP27A1 is the known causative gene of cerebrotendinous xanthomatosis, a disorder which is sometimes accompanied by early onset atherosclerosis. This and the observation of potentially harmful variations in unrelated CAD patients provide additional evidence for the suggested causative role of the p.Arg225His mutation in CAD.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CYP27A1; Coronary artery disease; Exome sequencing; Reverse cholesterol transport

Mesh:

Substances:

Year:  2013        PMID: 24080357     DOI: 10.1016/j.ejmg.2013.09.008

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  6 in total

Review 1.  Genetics of familial hypercholesterolemia.

Authors:  Ariel Brautbar; Emili Leary; Kristen Rasmussen; Don P Wilson; Robert D Steiner; Salim Virani
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

Review 2.  Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?

Authors:  Lăcrămioara Ionela Butnariu; Laura Florea; Minerva Codruta Badescu; Elena Țarcă; Irina-Iuliana Costache; Eusebiu Vlad Gorduza
Journal:  Life (Basel)       Date:  2022-06-09

Review 3.  Genetics of coronary artery disease and myocardial infarction.

Authors:  Xuming Dai; Szymon Wiernek; James P Evans; Marschall S Runge
Journal:  World J Cardiol       Date:  2016-01-26

Review 4.  Cardiac Involvement in Movement Disorders.

Authors:  Malco Rossi; Nestor Wainsztein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2021-04-07

5.  Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.

Authors:  Lan-Xiao Cao; Mi Yang; Ying Liu; Wen-Ying Long; Guo-Hua Zhao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

6.  Association of liver X receptor α (LXRα) gene polymorphism and coronary heart disease, serum lipids and glucose levels.

Authors:  Yun-Fei Zhou; Jing Zhang; Zong-Xue Li; Jing-Li Miao; Qiao-Xiang Yin; Jun-Jie Li; Xiao-Yan Zhang; Yuan-Yuan Li; Hui-Lan Luo
Journal:  Lipids Health Dis       Date:  2014-02-17       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.